Theratechnologies Inc T.TH

Lower SP Holdings

[SPCEO1]

We just filed our ownership position with the SEC. Our holdings have dropped considerably from last year but I never placed any sell orders in TH. We had a client who had a 7 figure amount of shares in his account die a couple of years ago and when his estate settled last year, most of his heirs took the assets to their own money managers. They may still own the stock but Stewardship Partners no longer manages those assets so it is not in our totals any longer. We also lost some other accounts over the last year which accounts for the rest of the decline in our ownership. 

We still own just under 4 million shares and are hoping this investment will finally start paying off for our clients (or paying off again might be a better way to put it).  

Other money manager should be reporting their holdings soon so it will be interesting to see what shows up. AIGH reduced their holdings slightly in the fourth quarter but most other hodlers have yet to report.

[palinc2000]

I read the 13 G Filing a few minutes before I saw your post......You gave me a heart beat skip moment  when I read th Filing ....Maybe THTX should put you in charge of writing theit Pr s. It was a good idea for you to clarify and provide explanations for the substantial reduction in shares controlled by your Fund

[FredTheVoice]

Not sure about that, Any business, or fund would be justify to have a lower position with what that company gave shareholders in the last couple of years, no need for explanations..... I am still positive for the future, but.....its a 50/50 game here...... FTV.

[palinc2000]

What are you not sure about?

[FredTheVoice]

"You gave me a heart beat skip moment  when I read th Filing" About that..... FTV.

[scarlet1967]

It looks like Soleus is accumulating quite a bit. https://fintel.io/so/us/thtx/soleus-capital-master-fund-l-p  

[LouisW]

It is difficult to predict the outcome of the trial or the partnership. However, two information are very important to me from an investors's perspective, Soleus and Morgan stanley trading as well as the insider trading. Big player like Soleus is accumulating the shares. They absolutely have the more sufficient resource to do the analysis prior to investing. It is a sign to me.

[palinc2000]

I had at the most a neutral reaction at Soleus initial investment in THTX via the OO...Funds do  take  risks and getting in early in the game is very risky but these funds are high risk tolerant and they win some and lose some..... However the fact that they have been accumulating wuite a lot according to the latest 14 G Filing is worthy of mention.......What are they relying on? Just

[scarlet1967]

Maybe the fact that the trial was/is still going on absent any bad surprises is good enough for them to think the risks are somehow getting more mitigated. To me the results for phase 1a isn't only about the therapeutic window, severity of the adverse effects,  PK/PD data/sortililn expression data and potential early anti cancer data but all of it. If they get favourable results even

[Wino115]

A top notch healtcare fund upping exposure in a very difficult market (and a tough performance year for them it appears, but just guessing at) is a very positive sign.  One thing they likely do beyond what we all know -that being, have super smart PhD analysts who understand these things as well as Christian, is to extensively plug-in to their network.  They may discuss the concept with

[palinc2000]

For the record I did not in any way suggest that they got different info from the company that us... I agree that they are not accumulating more  without having more info that us.....Access to the clinics or to patients in the trial?   If it were just opinions from oncology experts dont you think that the SP would have increased a lot since those experts are available to others

[Wino115]

Normally, I would also think the SP would respond as analysts would have KOLs on to talk with their clients about THTX, etc...  But in this case, I don't see anyone else who would bother digging in to it like that given the knowledge you need to put two-and-two together and the cost.  We know no analyst is doing things to spread the word like they should.  Maybe the AIGH guys or

[palinc2000]

I was just wondering if there is anything akin to channel checks done by analysts ahead of the curve to predict revenues in companies selling consumer goods and others,,,,,

[jfm1330]

I agree that a fund like Soleus can consult with expert knowing more about cancer in general and on the sortilin receptor. But without more data available to them from Thera, I don't think they can understand much more. There is no very complex science involved in SORT1+ and TH1902. Thera did not identify sortilin. Their key idea was to use it as a selective entry point into cancer cells

[Wino115]

Yeah, I don't think they would know a whole lot more about anything specifically going on scientifically or from the actual trial.  More about being able to tilt the field a bit on the future --so an inquiry with a KOL in an oncology setting to determine what the competition is in 4L mTNBC or the others, where would a PDC need to see it's RECIST data come in to perk up their ears

[PinnacleX]

And your gloating about the fact you havent sold?  Stunning ignorance.  How have these investors not sued you for what you have done.  Maybe, you should spend less time here and actually find stocks that are successful. 

[realitycheck4u]

This post has been removed in accordance with Community Policy

[SPCEO1]

Probably not as most of the shares left our oversight in early 2021.